The field of short-sellers has shrunk dramatically since the Department of Justice's probe was revealed earlier this year. However, some stalwart investors remain committed to the cause of unveiling potentially fraudulent companies.
Background On Cassava Sciences, Formerly Known As Pain Therapeutics
At the SohnX Hong Kong Conference, reputable short-seller Gabriel Grego of Quintessential Capital Management unmasked the individuals behind Cassava Sciences, previously known as Pain Therapeutics. He also explained why he sees problems at the company that has caused him to flag it as potentially fraudulent.
Q2 2022 hedge fund letters, conferences and more
This content is exclusively for paying members of Hedge Fund Alpha
Don’t have an account?
Subscribe now and get 7 days free!
Insider Strategies and Letters to Shareholders from the Top Hedge Funds
Exclusive Access to coverage of Private, Closed-Door Investor Conferences
Hedge Fund Manager Research Currently Producing 21% – 40% Returns AnnuallyDon’t have an account?
Subscribe now and get 7 days free!
